Johnson & Johnson
Johnson & Johnson Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 16,922 | 29.7 | 7.26 | 0.58 | 24,626.73 |
| Oct 2026 | 16,922 | 29.7 | 7.26 | 0.58 | 24,624.20 |
| Oct 2026 | 16,922 | 29.7 | 7.26 | 0.58 | 24,624.20 |
| Oct 2026 | 17,022 | 29.3 | 7.17 | 0.58 | 24,326.05 |
| Oct 2026 | 17,212 | 29.5 | 7.23 | 0.58 | 24,565.39 |
| Oct 2026 | 17,212 | 29.3 | 7.23 | 0.58 | 24,565.39 |
| Oct 2026 | 17,094 | 29.9 | 7.33 | 0.58 | 24,949.68 |
| Oct 2026 | 17,158 | 29.7 | 7.27 | 0.58 | 24,759.51 |
| Oct 2026 | 16,749 | 30.3 | 7.42 | 0.58 | 25,295.99 |
| Oct 2026 | 16,675 | 30.6 | 7.48 | 0.58 | 25,249.65 |
| Oct 2026 | 17,448 | 28.8 | 7.05 | 0.58 | 23,676.05 |
| Oct 2026 | 17,278 | 29.4 | 7.20 | 0.58 | 24,108.12 |
| Oct 2026 | 17,299 | 28.7 | 7.18 | 0.58 | 24,051.73 |
| Oct 2026 | 17,216 | 38.8 | 7.25 | 0.58 | 24,205.35 |
| Oct 2026 | 17,273 | 38.5 | 7.20 | 0.58 | 24,063.45 |
| Oct 2026 | 17,094 | 39.4 | 7.36 | 0.58 | 24,591.58 |
| Oct 2026 | 17,145 | 39.1 | 7.31 | 0.58 | 24,381.39 |
| Oct 2026 | 16,829 | 40.6 | 7.59 | 0.58 | 25,259.93 |
Johnson & Johnson Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 25,310,000,000.0 | 24,062,000,000.0 | 24,564,000,000.0 | 23,993,000,000.0 |
| Net Profit | 5,534,000,000.0 | 5,235,000,000.0 | 5,116,000,000.0 | 5,152,000,000.0 |
| EPS | 2.3 | 2.2 | 2.1 | 2.1 |
Johnson & Johnson Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 94,193,000,000.0 | 88,821,000,000.0 | 85,159,000,000.0 | 79,990,000,000.0 | — |
| Net Profit | 26,804,000,000.0 | 14,066,000,000.0 | 35,153,000,000.0 | 17,941,000,000.0 | — |
| EPS | 11.1 | 5.8 | 14.6 | 6.9 | — |
Johnson & Johnson Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 199,210,000,000.0 | 180,104,000,000.0 | 167,558,000,000.0 | 187,378,000,000.0 | — |
| Total Liabilities | 117,666,000,000.0 | 108,614,000,000.0 | 98,784,000,000.0 | 110,574,000,000.0 | — |
| Total Equity | 81,544,000,000.0 | 71,490,000,000.0 | 68,774,000,000.0 | 76,804,000,000.0 | — |
Owes vs Owns
Johnson & Johnson owed $0.58 for every $1 it owned in Jun 2026, down from $0.59 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.58× | 0.59× | 0.60× | 0.59× | 0.59× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Johnson & Johnson Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
How it's funded — Dec 2025
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 20,102.0 | 24,522.0 | 22,927.0 | 22,281.0 |
| Receivables | 21,331.0 | 18,927.0 | 19,387.0 | 16,915.0 |
| Inventory | 14,191.0 | 12,444.0 | 11,181.0 | 10,268.0 |
| Fixed assets (tangible) | 23,169.0 | 20,518.0 | 19,898.0 | 17,982.0 |
| Intangible assets | 99,175.0 | 81,818.0 | 70,733.0 | 74,536.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 21,242.0 | 21,875.0 | 23,432.0 | 45,396.0 |
| Liabilities & equity | ||||
| Short-term debt | 8,495.0 | 5,983.0 | 3,451.0 | 12,756.0 |
| Long-term debt | 39,438.0 | 30,651.0 | 25,881.0 | 26,886.0 |
| Payables | 11,991.0 | 10,311.0 | 9,632.0 | 9,889.0 |
| Other liabilities | 57,742.0 | 61,669.0 | 59,820.0 | 61,043.0 |
| Shareholders' equity | 81,544.0 | 71,490.0 | 68,774.0 | 76,804.0 |
| Net tangible assets | -17,631.0 | -10,328.0 | -1,959.0 | 2,268.0 |
Johnson & Johnson Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Operating Activities | 24,530,000,000.0 | 24,266,000,000.0 | 22,791,000,000.0 | 21,194,000,000.0 |
| Investing Activities | -23,588,000,000.0 | -18,599,000,000.0 | 878,000,000.0 | -12,371,000,000.0 |
| Financing Activities | -5,539,000,000.0 | -3,132,000,000.0 | -15,825,000,000.0 | -8,871,000,000.0 |